PSY 627 Exam 2 Questions With Correct
Answers
What |overall |class |of |medical |conditions |represents |the |most |common |and |serious |SEs |of |the |
5-HT2A |antagonists/D2 |antagonists? |- |CORRECT |ANSWER✔✔-Cardiometabolic |SEs
Cardiometabolic |SEs |are |the |most |common |class |of |medical |conditions:
- |___ |___ |(especially |in |adolescents)
- |___ |(high |level |of |triglycerides |[lipids])
- |___ |(high |blood |sugar |and |risk |of |type |II |diabetes) |- |CORRECT |ANSWER✔✔-Weight |gain
Dyslipidemia
Hyperglycemia
Antagonism |of |the |___ |(___-___) |receptor |may |cause |dizziness |and |orthostasis |(postural |
hypotension) |which |may |cause |falls. |
This |is |due |to |an |arteriole* |constricting |when |NE |binds |to |an |___ |receptor |which |raises |blood |
pressure |and |helps |maintain |blood |to |the |brain |when |one |sits |up |or |stands |up |after |lying |
down. |- |CORRECT |ANSWER✔✔-α1 |(alpha-adrenergic)
α1
Some |5-HT2A |antagonists/D2 |antagonists |are |"mood |stabilizers" |and |may |be |useful |as:
- |Treatment |of |___ |___: |acute |mania/mixed, |depression, |maintenance
- |Augmenting |agents |for |___-___ |depression
, - |Increasing |levels |of |5-HT, |DA, |NE |resulting |in |less |___ |- |CORRECT |ANSWER✔✔-bipolar |
disorder
treatment-resistant
depression
The |specific |___ |of |drugs |with |antipsychotic |effects |differ |and |are |often |one |of |the |main |
determining |factors |for |choosing |a |specific |drug |for |a |particular |patient. |- |CORRECT |
ANSWER✔✔-SEs
In |patients |with |schizophrenia:
- |5-HT2A |antagonists/D2 |antagonists |generally |decrease |___-___%* |of |symptoms
- |___ |symptoms |may |decrease |in |a |few |days
- |Remission |of |___, |___, |and |___ |symptoms |may |take |months, |if |at |all |- |CORRECT |
ANSWER✔✔-20-50
Positive
cognitive
negative |
affective
___ |___ |is |the |most |common |reason |for |poor |responses |(partial |responses |or |symptom |
relapses) |to |a |drug |with |antipsychotic |effects. |- |CORRECT |ANSWER✔✔-Poor |adherence
Poor |adherence |to |a |drug |with |antipsychotic |effects |usually |occurs |due |to |___.
- |If |___ |don't |decrease:
Treat |with |adjuvant |drugs
Switch |drugs |- |CORRECT |ANSWER✔✔-SEs
SEs
Answers
What |overall |class |of |medical |conditions |represents |the |most |common |and |serious |SEs |of |the |
5-HT2A |antagonists/D2 |antagonists? |- |CORRECT |ANSWER✔✔-Cardiometabolic |SEs
Cardiometabolic |SEs |are |the |most |common |class |of |medical |conditions:
- |___ |___ |(especially |in |adolescents)
- |___ |(high |level |of |triglycerides |[lipids])
- |___ |(high |blood |sugar |and |risk |of |type |II |diabetes) |- |CORRECT |ANSWER✔✔-Weight |gain
Dyslipidemia
Hyperglycemia
Antagonism |of |the |___ |(___-___) |receptor |may |cause |dizziness |and |orthostasis |(postural |
hypotension) |which |may |cause |falls. |
This |is |due |to |an |arteriole* |constricting |when |NE |binds |to |an |___ |receptor |which |raises |blood |
pressure |and |helps |maintain |blood |to |the |brain |when |one |sits |up |or |stands |up |after |lying |
down. |- |CORRECT |ANSWER✔✔-α1 |(alpha-adrenergic)
α1
Some |5-HT2A |antagonists/D2 |antagonists |are |"mood |stabilizers" |and |may |be |useful |as:
- |Treatment |of |___ |___: |acute |mania/mixed, |depression, |maintenance
- |Augmenting |agents |for |___-___ |depression
, - |Increasing |levels |of |5-HT, |DA, |NE |resulting |in |less |___ |- |CORRECT |ANSWER✔✔-bipolar |
disorder
treatment-resistant
depression
The |specific |___ |of |drugs |with |antipsychotic |effects |differ |and |are |often |one |of |the |main |
determining |factors |for |choosing |a |specific |drug |for |a |particular |patient. |- |CORRECT |
ANSWER✔✔-SEs
In |patients |with |schizophrenia:
- |5-HT2A |antagonists/D2 |antagonists |generally |decrease |___-___%* |of |symptoms
- |___ |symptoms |may |decrease |in |a |few |days
- |Remission |of |___, |___, |and |___ |symptoms |may |take |months, |if |at |all |- |CORRECT |
ANSWER✔✔-20-50
Positive
cognitive
negative |
affective
___ |___ |is |the |most |common |reason |for |poor |responses |(partial |responses |or |symptom |
relapses) |to |a |drug |with |antipsychotic |effects. |- |CORRECT |ANSWER✔✔-Poor |adherence
Poor |adherence |to |a |drug |with |antipsychotic |effects |usually |occurs |due |to |___.
- |If |___ |don't |decrease:
Treat |with |adjuvant |drugs
Switch |drugs |- |CORRECT |ANSWER✔✔-SEs
SEs
